Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1996 1
2011 7
2012 6
2013 10
2014 10
2015 20
2016 9
2017 13
2018 5
2019 5
2020 7
2021 6
2022 5
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion.
Leuzzi G, Vasciaveo A, Taglialatela A, Chen X, Firestone TM, Hickman AR, Mao W, Thakar T, Vaitsiankova A, Huang JW, Cuella-Martin R, Hayward SB, Kesner JS, Ghasemzadeh A, Nambiar TS, Ho P, Rialdi A, Hebrard M, Li Y, Gao J, Gopinath S, Adeleke OA, Venters BJ, Drake CG, Baer R, Izar B, Guccione E, Keogh MC, Guerois R, Sun L, Lu C, Califano A, Ciccia A. Leuzzi G, et al. Cell. 2024 Feb 15;187(4):861-881.e32. doi: 10.1016/j.cell.2024.01.008. Epub 2024 Jan 31. Cell. 2024. PMID: 38301646
The DNA Damage Response and Inflammation in Cancer.
Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. Klapp V, et al. Among authors: leuzzi g. Cancer Discov. 2023 Jul 7;13(7):1521-1545. doi: 10.1158/2159-8290.CD-22-1220. Cancer Discov. 2023. PMID: 37026695
Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
Li Y, Goldberg EM, Chen X, Xu X, McGuire JT, Leuzzi G, Karagiannis D, Tate T, Farhangdoost N, Horth C, Dai E, Li Z, Zhang Z, Izar B, Que J, Ciccia A, Majewski J, Yoon AJ, Ailles L, Mendelsohn CL, Lu C. Li Y, et al. Among authors: leuzzi g. Mol Cell. 2022 Oct 20;82(20):3901-3918.e7. doi: 10.1016/j.molcel.2022.09.007. Epub 2022 Oct 6. Mol Cell. 2022. PMID: 36206767 Free PMC article.
HATtracting Nucleases to Stalled Forks.
Leuzzi G, Taglialatela A, Ciccia A. Leuzzi G, et al. Mol Cell. 2020 Oct 15;80(2):177-180. doi: 10.1016/j.molcel.2020.09.031. Mol Cell. 2020. PMID: 33065018 Free article.
Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
Prinzi N, Rossi RE, Proto C, Leuzzi G, Raimondi A, Torchio M, Milione M, Corti F, Colombo E, Prisciandaro M, Cascella T, Spreafico C, Beninato T, Coppa J, Lo Russo G, Di Bartolomeo M, de Braud F, Pusceddu S. Prinzi N, et al. Among authors: leuzzi g. Clin Lung Cancer. 2021 May;22(3):161-169. doi: 10.1016/j.cllc.2020.12.004. Epub 2020 Dec 17. Clin Lung Cancer. 2021. PMID: 33618994 Review.
Treatment of anaemia in the "ERAS" era: how far can we go?
Rolli L, Duranti L, Leuzzi G. Rolli L, et al. Among authors: leuzzi g. J Thorac Dis. 2019 Sep;11(9):3692-3695. doi: 10.21037/jtd.2019.09.21. J Thorac Dis. 2019. PMID: 31656640 Free PMC article. No abstract available.
108 results